Detalles de la búsqueda
1.
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia.
Clin Cancer Res
; 11(17): 6247-55, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16144928
2.
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
J Clin Oncol
; 33(32): 3733-40, 2015 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324362
3.
Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 13(6): 500-4, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23063071
4.
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 68(5): 1199-206, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21409383
5.
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.
J Clin Oncol
; 29(11): 1465-71, 2011 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21383294
Resultados
1 -
5
de 5
1
Próxima >
>>